Caspofungin in the Treatment of Azole-Refractory Esophageal Candidiasis in Kidney Transplant Recipients

Transplantation Proceedings

Volumn 38, Issue 4, 2006, Pages 1037-1039

  Veroux, M ^a   Macarone, M ^a   Fiamingo, P ^a   Cappello, D ^a   Gagliano, M ^a   Di Mare, M ^a   Vizcarra, D ^a   Spataro, M ^a   Giuffrida, G ^a   Sorbello, M ^a   Severino, V ^a   Veroux, P ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; PYRROLE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; DRUG TOLERABILITY; ESOPHAGUS CANDIDIASIS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFECTION RISK; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; THRUSH; VAGINA CANDIDIASIS;

ADULT; AGED; ANTIFUNGAL AGENTS; CANDIDIASIS; CANDIDIASIS, VULVOVAGINAL; CYCLOSPORINE; ESOPHAGEAL DISEASES; FEMALE; FLUCONAZOLE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; MIDDLE AGED; PEPTIDES, CYCLIC; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TACROLIMUS; TIME FACTORS;

EID: 33744522823     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.03.050     Document Type: Article

References (12)

1. Ko K.S., Cho J.H., Ahn J.H., et al. Infections after renal transplantation. Transplant Proc 26 (1994) 2072
2. Sia I.G., and Paya C.V. Infectious complications following renal transplantation. Surg Clin North Am 78 (1998) 96
3. Herzog C.A., Ma J.Z., and Collins A.J. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 339 (1998) 799
4. Schmidt A., and Oberbauer R. Bacterial and fungal infections after kidney transplantation. Curr Opin Urol 9 (1999) 45
5. Abbott K.C., Hypolite I., Poropatich R.K., et al. Hospitalizations for fungal infections after renal transplantation in the United States. Transpl Infect Dis 3 (2001) 203
6. Gupta K.L., Ghosh A.K., Kochhar R., et al. Esophageal candidiasis after renal transplantation. comparative study in patients under different immunosuppressive protocols. Am J Gastroenterol 89 (1994) 1062
7. Rex J.H., Bennett J.E., Sugar A.M., et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 331 (1994) 1325
8. Villanueva A., Gotuzzo E., Arathoon E., et al. A randomized double-blind study of caspofungin versus fluconazole for the treatment of oesophageal candidiasis. Am J Med 113 (2002) 294
9. Denning D.W. Echinocandin antifungal drugs. Lancet 362 (2003) 1142
10. Arathoon E.G., Gotuzzo E., Noriega L.M., et al. Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases. Antimicrob Agents Chemother 46 (2002) 451
11. Deresinski S.C., and Stevens D.A. Caspofungin. Clin Infect Dis 36 (2003) 1445
12. Garbino J. Caspofungin-a new therapeutic option for oropharyngeal candidiasis. Clin Microbiol Infect 10 (2004) 187